General Nurse Practitioner News

NP

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bays HE et al. - Colesevelam improves glycemic and lipid parameters in patients with T2DM inadequately controlled with metformin-based therapy.

Related Articles

Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without causing weight gain or increased hypoglycaemia
Diabetes, Obesity and Metabolism, 11/12/09    Relevance Score: 100%

Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes
Hormone and Metabolic Research, 11/02/09    Relevance Score: 100%

Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM
Current Medical Research and Opinion, 10/22/09    Relevance Score: 100%

Long-term effects of pioglitazone in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity
Current Medical Research and Opinion, 10/19/09    Relevance Score: 100%

Beyond Glycemic Control: Treating the Entire Type 2 Diabetes Disorder
Postgraduate Medicine, 10/05/09    Relevance Score: 100%

Today in Clinical Pharmacology...keeping you current

Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid
Journal of Allergy and Clinical Immunology, 12/08/09

Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma
Journal of Allergy and Clinical Immunology, 12/08/09

In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii
The Journal of Antibiotics, 12/08/09